Organocatalyzed umpolung addition for synthesis of heterocyclic-fused arylidene-imidazolones as anticancer agents, Gulshan Kumar, Chinmay Das, Ayan Acharya, Subhasmita Bhal, Mayank Joshi, Chanakya Nath Kundu, Angshuman Roy Choudhury, Sankar K Guchhait, Bioorg. Med. Chem., 2022, 67, 116835.
Exploration of Benzo[b]carbazole-6,11-diones as anticancer agents: Synthesis and studies of hTopoIIα inhibition and apoptotic effects, Shailendra Sisodiy, Subarno Paul, Hitesh K. Chaudhary, Preeti Grewal, Gulshan Kumar, Divine P Daniel, Biswajit Das, Deepika Nayak, Sankar K. Guchhait, * Chanakya N. Kundu, Uttam C. Banerjee, Bioorg. Med. Chem. Lett. 2021, 49, 128274.
Pharmacoinformatics analysis of merbarone binding site in human topoisomerase IIa, Neha Tripathi, Sankar K. Guchhait, Prasad V. Bharatam, J. Mol. Graph. Model., 2019, 1, 1-18.
Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-a] pyridinones as topoisomerase IIα inhibiting anticancer agents, Garima Priyadarshani, Anmada Nayak, Suyog M. Amrutkar, Sarita Das, Sankar K. Guchhait, Chanakya N. Kundu, and Uttam C. Banerjee, ACS Med. Chem. Lett. 2016, 7, 1056−1061.
Scaffold-hopping of bioactive flavonoids: Discovery of arylpyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα, Garima Priyadarshani, Suyog Amrutkar, Anmada Nayak, Uttam C. Banerjee, Chanakya N. Kundu, Sankar K. Guchhait, Eur. J. Med. Chem. 2016, 122, 43-54.
Switch in site of inhibition: a strategy for structure-based discovery of human topoisomerase IIα catalytic inhibitors, Baviskar, A. T.; Amrutkar, S. M.; Trivedi, N.; Chaudhary, V.; Nayak, A.; Guchhait, S. K.; Banerjee, U. C.; Bharatam, P.V.; Kundu, C. N. ACS Med. Chem. Lett., 2015, 6, 481-485. (This article/work was considered by the Editor, as an excellent piece of research and was highlighted by featuring it as cover art image in one of the issues (April, 2015) of the ACS Med. Chem. Lett.)